The drug has brought relief to children suffering from cancer and other serious ailments, but getting access is often limited by considerable regulatory hurdles.
Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism
After numerous high-profile safety scares, clinicians and regulators push to fix critical weaknesses in the FDA’s monitoring system for approved drugs.
A US federal court rules that procedures in which a patient's own stem cells are extracted, manipulated, and reinjected should be regulated by the FDA.
Science adviser John Holdren speaks out about how the Presidential Administration is handling the controversial research that rendered avian flu transmissible between ferrets.
A new policy will require federal agencies to perform a careful review of research involving 15 pathogens and toxins that could be used for bioterrorism, including H5N1.